|
Iqvia Holdings
(IQV)
|
4.4 |
$539M |
|
3.8M |
141.88 |
|
Fidelity National Information Services
(FIS)
|
4.0 |
$481M |
|
3.6M |
134.09 |
|
IAC/InterActive
|
3.7 |
$456M |
|
1.4M |
323.40 |
|
Centene Corporation
(CNC)
|
3.7 |
$445M |
|
7.0M |
63.55 |
|
Abbvie
(ABBV)
|
3.3 |
$407M |
|
4.2M |
98.18 |
|
Thermo Fisher Scientific
(TMO)
|
3.2 |
$388M |
|
1.1M |
362.34 |
|
Charter Communications Inc N Cl A
(CHTR)
|
3.2 |
$385M |
|
755k |
510.04 |
|
Metropcs Communications
(TMUS)
|
3.0 |
$360M |
|
3.5M |
104.15 |
|
Visa Com Cl A
(V)
|
2.9 |
$348M |
|
1.8M |
193.17 |
|
Aon Shs Cl A
(AON)
|
2.7 |
$331M |
|
1.7M |
192.60 |
|
Anthem
(ELV)
|
2.7 |
$329M |
|
1.3M |
262.98 |
|
Alphabet Cap Stk Cl C
(GOOG)
|
2.6 |
$313M |
|
221k |
1413.61 |
|
Microsoft Corporation
(MSFT)
|
2.6 |
$311M |
|
1.5M |
203.51 |
|
Facebook Cl A
(META)
|
2.5 |
$309M |
|
1.4M |
227.07 |
|
Ihs Markit SHS
|
2.4 |
$295M |
|
3.9M |
75.50 |
|
salesforce
(CRM)
|
2.3 |
$286M |
|
1.5M |
187.33 |
|
58 Spon Adr Rep A
|
2.2 |
$268M |
|
5.0M |
53.94 |
|
Sherwin-Williams Company
(SHW)
|
2.1 |
$259M |
|
448k |
577.85 |
|
Wabtec Corporation
(WAB)
|
2.0 |
$249M |
|
4.3M |
57.57 |
|
Exelixis
(EXEL)
|
2.0 |
$243M |
|
10M |
23.74 |
|
Bristol Myers Squibb
(BMY)
|
1.7 |
$213M |
|
3.6M |
58.80 |
|
Acceleron Pharma
|
1.6 |
$200M |
|
2.1M |
95.27 |
|
Alibaba Group Hldg Sponsored Ads
(BABA)
|
1.6 |
$200M |
|
927k |
215.70 |
|
Palo Alto Networks
(PANW)
|
1.6 |
$196M |
|
852k |
229.67 |
|
Equinix
(EQIX)
|
1.5 |
$188M |
|
268k |
702.30 |
|
Iovance Biotherapeutics
(IOVA)
|
1.5 |
$180M |
|
6.5M |
27.45 |
|
New York Times Cl A
(NYT)
|
1.4 |
$174M |
|
4.1M |
42.03 |
|
General Dynamics Corporation
(GD)
|
1.4 |
$172M |
|
1.2M |
149.46 |
|
Ascendis Pharma A S Sponsored Adr
(ASND)
|
1.4 |
$169M |
|
1.1M |
147.90 |
|
Bristol-myers Squibb Right 99/99/9999
|
1.3 |
$158M |
|
44M |
3.58 |
|
Blackstone Group Com Cl A
(BX)
|
1.3 |
$157M |
|
2.8M |
56.66 |
|
Alnylam Pharmaceuticals
(ALNY)
|
1.3 |
$156M |
|
1.1M |
148.11 |
|
Qiagen Nv Shs New
|
1.0 |
$123M |
|
2.9M |
42.81 |
|
Fate Therapeutics
(FATE)
|
1.0 |
$120M |
|
3.5M |
34.31 |
|
Playa Hotels & Resorts Nv SHS
(PLYA)
|
0.9 |
$111M |
|
31M |
3.62 |
|
Transunion
(TRU)
|
0.9 |
$104M |
|
1.2M |
87.04 |
|
Caesars Entertainment
|
0.8 |
$97M |
|
8.0M |
12.13 |
|
Cigna Corp
(CI)
|
0.8 |
$94M |
|
500k |
187.65 |
|
Broadmark Rlty Cap
|
0.7 |
$91M |
|
9.6M |
9.47 |
|
Enanta Pharmaceuticals
(ENTA)
|
0.7 |
$88M |
|
1.8M |
50.21 |
|
Myokardia
|
0.7 |
$85M |
|
875k |
96.62 |
|
Sarepta Therapeutics
(SRPT)
|
0.7 |
$84M |
|
525k |
160.34 |
|
New Oriental Ed & Technology Spon Adr
|
0.7 |
$82M |
|
631k |
130.23 |
|
Mirati Therapeutics
|
0.6 |
$74M |
|
650k |
114.17 |
|
Apellis Pharmaceuticals
(APLS)
|
0.6 |
$74M |
|
2.3M |
32.66 |
|
Agios Pharmaceuticals
(AGIO)
|
0.5 |
$67M |
|
1.3M |
53.48 |
|
Fibrogen
|
0.5 |
$66M |
|
1.6M |
40.53 |
|
Momo Note 1.250% 7/0 (Principal)
|
0.5 |
$64M |
|
82M |
0.79 |
|
Karuna Therapeutics Ord
|
0.5 |
$64M |
|
575k |
111.46 |
|
Iqiyi Note 2.000% 4/0 (Principal)
|
0.5 |
$61M |
|
61M |
1.00 |
|
Grifols S A Sp Adr Rep B Nvt
(GRFS)
|
0.5 |
$57M |
|
3.1M |
18.24 |
|
Arena Pharmaceuticals Com New
|
0.5 |
$57M |
|
900k |
62.95 |
|
Zogenix Com New
|
0.4 |
$54M |
|
2.0M |
27.01 |
|
Karyopharm Therapeutics Note 3.000%10/1 (Principal)
|
0.4 |
$50M |
|
35M |
1.43 |
|
Zentalis Pharmaceuticals
(ZNTL)
|
0.4 |
$48M |
|
991k |
48.02 |
|
Generation Bio
|
0.4 |
$45M |
|
2.1M |
21.00 |
|
Protagonist Therapeutics
(PTGX)
|
0.4 |
$44M |
|
2.5M |
17.66 |
|
Equifax
(EFX)
|
0.4 |
$44M |
|
255k |
171.88 |
|
Deciphera Pharmaceuticals
|
0.4 |
$43M |
|
715k |
59.72 |
|
United Therapeutics Corporation
(UTHR)
|
0.3 |
$42M |
|
350k |
121.00 |
|
Theravance Biopharma Note 3.250%11/0 (Principal)
|
0.3 |
$41M |
|
42M |
0.98 |
|
Cara Therapeutics
|
0.3 |
$39M |
|
2.3M |
17.10 |
|
Lantheus Holdings Inc Common Stock Usd 0.01
(LNTH)
|
0.3 |
$38M |
|
2.6M |
14.30 |
|
Cytokinetics Com New
(CYTK)
|
0.3 |
$35M |
|
1.5M |
23.57 |
|
Sage Therapeutics
(SAGE)
|
0.3 |
$35M |
|
850k |
41.58 |
|
Arrowhead Pharmaceuticals
(ARWR)
|
0.3 |
$35M |
|
800k |
43.19 |
|
Portola Pharmaceuticals
|
0.3 |
$33M |
|
1.8M |
17.99 |
|
Iqiyi Note 3.750%12/0 (Principal)
|
0.3 |
$33M |
|
30M |
1.12 |
|
Clovis Oncology Note 1.250% 5/0 (Principal)
|
0.3 |
$31M |
|
52M |
0.60 |
|
Amyris Com New
|
0.2 |
$30M |
|
7.0M |
4.27 |
|
Horizon Pharma Invt Note 2.500% 3/1 (Principal)
|
0.2 |
$29M |
|
15M |
1.95 |
|
Tg Therapeutics
(TGTX)
|
0.2 |
$29M |
|
1.5M |
19.48 |
|
Radius Health Com New
|
0.2 |
$29M |
|
2.1M |
13.63 |
|
Forescout Technologies
|
0.2 |
$28M |
|
1.3M |
21.20 |
|
Pliant Therapeutics
(PLRX)
|
0.2 |
$28M |
|
851k |
32.46 |
|
Avrobio Ord
(AVRO)
|
0.2 |
$28M |
|
1.6M |
17.45 |
|
Karyopharm Therapeutics
|
0.2 |
$25M |
|
1.3M |
18.94 |
|
Adaptimmune Therapeutics Sponds Adr
(ADAP)
|
0.2 |
$25M |
|
2.5M |
10.01 |
|
Arcus Biosciences Incorporated
(RCUS)
|
0.2 |
$25M |
|
1.0M |
24.74 |
|
Ishares Tr China Lg-cap Etf Put Option
(FXI)
|
0.2 |
$22M |
|
563k |
39.70 |
|
Veracyte
(VCYT)
|
0.2 |
$22M |
|
850k |
25.90 |
|
Amarin Corp Spons Adr New
|
0.2 |
$22M |
|
3.1M |
6.92 |
|
Gossamer Bio Note 5.000% 6/0 (Principal)
|
0.2 |
$20M |
|
20M |
1.00 |
|
Invitae
(NVTAQ)
|
0.2 |
$20M |
|
657k |
30.29 |
|
Zymeworks
|
0.2 |
$20M |
|
550k |
36.07 |
|
Howmet Aerospace
(HWM)
|
0.2 |
$19M |
|
1.2M |
15.85 |
|
Intercept Pharmaceuticals In Note 2.000% 5/1 (Principal)
|
0.2 |
$19M |
|
26M |
0.74 |
|
Krystal Biotech
(KRYS)
|
0.2 |
$19M |
|
450k |
41.42 |
|
Principia Biopharma
|
0.1 |
$18M |
|
300k |
59.79 |
|
Zealand Pharma A S Sponsored Adr
|
0.1 |
$18M |
|
500k |
35.00 |
|
Liquidia Technologies
(LQDA)
|
0.1 |
$16M |
|
1.9M |
8.42 |
|
Tricida
|
0.1 |
$14M |
|
500k |
27.48 |
|
Uniqure Nv SHS
(QURE)
|
0.1 |
$14M |
|
300k |
45.06 |
|
Royalty Pharma Shs Cl A
(RPRX)
|
0.1 |
$13M |
|
275k |
48.55 |
|
Ready Cap Corp Com reit
(RC)
|
0.1 |
$12M |
|
1.4M |
8.69 |
|
Savara
(SVRA)
|
0.1 |
$11M |
|
4.5M |
2.49 |
|
Crispr Therapeutics Namen Akt
(CRSP)
|
0.1 |
$11M |
|
150k |
73.49 |
|
Constellation Pharmceticls I
|
0.1 |
$11M |
|
350k |
30.05 |
|
Pacific Biosciences of California
(PACB)
|
0.1 |
$10M |
|
3.0M |
3.45 |
|
Akebia Therapeutics
(AKBA)
|
0.1 |
$10M |
|
750k |
13.58 |
|
Atento S A SHS
|
0.1 |
$7.7M |
|
11M |
0.69 |
|
Akouos
|
0.0 |
$5.1M |
|
225k |
22.50 |
|
Applied Molecular Trans
|
0.0 |
$5.0M |
|
200k |
25.14 |
|
Radius Health Note 3.000% 9/0 (Principal)
|
0.0 |
$5.0M |
|
6.8M |
0.74 |
|
Intercept Pharmaceuticals In Note 3.250% 7/0 (Principal)
|
0.0 |
$4.8M |
|
6.5M |
0.74 |
|
Repare Therapeutics Ord
(RPTX)
|
0.0 |
$4.7M |
|
150k |
31.02 |
|
Arya Sciences Acquistion Unit 06/09/2027
|
0.0 |
$4.6M |
|
400k |
11.60 |
|
Fusion Pharmaceuticals
|
0.0 |
$4.4M |
|
250k |
17.47 |
|
Iveric Bio
|
0.0 |
$3.8M |
|
750k |
5.10 |
|
Ctrip Com Intl DBCV 1.990% 7/0 (Principal)
|
0.0 |
$3.5M |
|
3.5M |
0.99 |
|
Dermtech Ord ord
(DMTKQ)
|
0.0 |
$2.6M |
|
195k |
13.23 |
|
Broadmark Rlty Cap *w Exp 11/15/202
|
0.0 |
$2.3M |
|
7.2M |
0.32 |
|
Avidity Biosciences Ord
(RNA)
|
0.0 |
$1.4M |
|
50k |
28.26 |
|
Gossamer Bio
(GOSS)
|
0.0 |
$1.3M |
|
100k |
13.00 |
|
Cytomx Therapeutics
(CTMX)
|
0.0 |
$1.2M |
|
149k |
8.33 |
|
Gol Linhas Aereas Inteligent Spon Adr Pfd New
|
0.0 |
$582k |
|
86k |
6.78 |